Over the past five years, the cosmetic industry has met with several legislative changes. Within the new legislative package, including the new REACH and CLP, it is important to find a comfortable routine that will minimize costs while staying effective and compliant with all regulations.
When QUALITY meets OPEX in manufacturing
PHARMA and Biotech leaders understand the importance of shifting from a culture of compliance to a culture of quality.
Times of transformation call for increasing overall quality and efficiency while lowering costs in order to follow regulations and maintain a competitive edge.
Can you sustain the leadership commitment and employee engagement required in the continuous improvement of quality? Do you know how to overcome resistance to change and successfully lead engaged employees who see the importance of the overall strategy?
On 22 – 23 September 2016, Vienna will be the place where Quality meets OPEX. Organized by Fleming., delegates will have the unique opportunity to attend two events in one and meet 100+ industry professionals under one roof.
At the 12th Annual Quality in Pharma & Biotech Forum, participants will discuss with leading experts how to translate a quality culture into operations and close the loop on their desired level of quality. They will gain insight into GMP inspection trends, data integrity requirements, quality metrics, Lean Six Sigma approach in a quality unit, CMO quality oversight, quality risk management in issue handling, serialization and technology transfer strategies.
The 12th Annual OPEX in Pharma & Biotech Forum will provide insights into developing defect-free processes. Attendees will find out how to achieve manufacturing excellence through more competitive improvement strategies in Digitalization, Six Sigma and advanced technologies such as 3D printing. Experts will explain how to lead initiatives even further, develop operating models in an autonomous work environment and create strong learning loops to adjust the operational excellence approach.
One day prior to the event, on 21 September, a pre-conference site visit to the facilities of Baxalta, one of the largest biopharma companies in Austria, will be prepared for interested participants.
Interested in this topic?
Advanced Protein Aggregation & Characterization
This training will focus on occurrence of particles in drug products, effects of protein aggregates, critical process and parameters. Attendees will gain overview of on utility and limits of predictive experiments, learn concerns from the authorities and relevant aggregation guidelines, and more.
Corporate Compliance & Transparency in the Pharmaceutical Industry
This two-day conference will serve as a platform for an open and dynamic dialogue with HCPs and patients to achieve common goals. Learn how to embed compliance in the business and develop one simple system for managing compliance & transparency in a complex and regulated environment.